½ÃÀ庸°í¼­
»óǰÄÚµå
1596172

¼¼°èÀÇ ±¼Àý±³Á¤ ¼ö¼ú ±â±â ½ÃÀå : ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Refractive Surgery Devices Market by Product Type (Aberrometers, Microkeratome, Ophthalmic Laser), Application (Astigmatism, Dry Eyes, Farsightedness), End-Use - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 187 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

±¼Àý±³Á¤ ¼ö¼ú ±â±â(Refractive Surgery Devices) ½ÃÀåÀº 2023³â 2¾ï 1,711¸¸ ´Þ·¯·Î Æò°¡µÇ¾úÀ¸¸ç, 2024³â 2¾ï 3,613¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, CAGR 8.85%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 3¾ï 9,312¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

±¼Àý±³Á¤ ¼ö¼ú ±â±â´Â ÁÖ·Î ¶ó½Ä, PRK, ½º¸¶Àϰú °°Àº ½Ã¼úÀ» ÅëÇØ ±Ù½Ã, ÃʽÃ, ³­½Ã¿Í °°Àº ½Ã·Â ¹®Á¦¸¦ ±³Á¤ÇÏ´Â µ¥ »ç¿ëµÇ´Â Ư¼ö µµ±¸¿Í ±â¼úÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â±âÀÇ Çʿ伺Àº ½Ã°¢ Àå¾ÖÀÇ À¯º´·üÀÌ Áõ°¡ÇÏ°í ±âÁ¸ ¾È°æ°ú ÄÜÅÃÆ®·»Á´Ù ½Ã·Â ±³Á¤ ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ºñ·ÔµË´Ï´Ù. ÁÖ·Î ¾È°ú¿Í º´¿ø¿¡¼­ ¿µ±¸ÀûÀÎ ½Ã·Â ¼Ö·ç¼ÇÀ» ã´Â ´Ù¾çÇÑ ¿¬·É´ë¿¡ ¸ÂÃç Àû¿ëµË´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ¿¡´Â °³¼±µÈ ȯÀÚ Ä¡·á¸¦ Á¦°øÇϱâ À§ÇØ ÀÌ·¯ÇÑ Ã·´Ü ±â±â¿¡ ÅõÀÚÇÏ´Â ¾È°ú ÀÇ»ç¿Í ÀÇ·á ½Ã¼³ÀÌ Æ÷ÇԵ˴ϴÙ. ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ¼ö¼ú ±â±âÀÇ ±â¼ú ¹ßÀü, ±¼Àý ¼ö¼ú¿¡ ´ëÇÑ È¯ÀÚ ÀÎ½Ä Áõ°¡, ÀÇ·á ÁöÃâ Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ħÅõÇÏÁö ¾ÊÀº °í°´ ±â¹Ý°ú ±â±â Çõ½Å¿¡ ÁßÁ¡À» µÐ ÷´Ü ±â¼ú ±â¾÷°úÀÇ ÀáÀçÀû ÆÄÆ®³Ê½ÊÀ¸·Î ÀÎÇØ ½ÅÈï ½ÃÀå¿¡¼­ ±âȸ°¡ dzºÎÇÕ´Ï´Ù. ±×·¯³ª ½ÃÀå ¼ºÀåÀº ³ôÀº ±â±â ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, ȯÀÚÀÇ ÁÖÀúÇÔÀ¸·Î À̾îÁö´Â ¼ö¼ú ÀýÂ÷¿Í °ü·ÃµÈ ÀáÀçÀû À§Çè°ú °°Àº µµÀü¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ °³¹ß Áö¿ª¿¡ ¼÷·ÃµÈ Àü¹®°¡ ºÎÁ·°ú ´ëü ºñ¼ö¼úÀû ±³Á¤ ¹æ¹ýÀÇ °¡¿ë¼ºµµ ÇѰ迡 Á÷¸éÇØ ÀÖ½À´Ï´Ù. ºñÁî´Ï½º ¼ºÀåÀ» ÃËÁøÇϱâ À§ÇØ ±â¾÷Àº ºñ¿ë È¿À²ÀûÀÌ°í ¾ÈÀüÇÏ¸ç ´ú ħ½ÀÀûÀÎ ¼ö¼ú ¹æ¹ýÀ» °³¹ßÇϱâ À§ÇØ R&D¿¡ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù. Çõ½Å ºÐ¾ß¿¡´Â ´õ ³ªÀº Á¤¹Ðµµ ¹× ·Îº¿ ¼ö¼ú Áö¿øÀ» À§ÇÑ Çâ»óµÈ ¿µ»ó ½Ã½ºÅÛÀÌ Æ÷Ç﵃ ¼ö ÀÖ½À´Ï´Ù. ±Þ°ÝÇÑ ±â¼ú º¯È­·Î ÀÎÇØ °æÀï ¿ªÇÐ °ü°è°¡ Ä¡¿­ÇØÁ® ½ÃÀåÀÌ °íµµ·Î Çõ½Å Áß½ÉÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¼ö¼ú °á°ú¸¦ ¿¹ÃøÇϱâ À§ÇØ AI ¹× ¸Ó½Å ·¯´×¿¡ ÅõÀÚÇÏ´Â ±â¾÷Àº °æÀï ¿ìÀ§¸¦ È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ¼Ö·ç¼ÇÀ» Æ÷ÇÔÇϵµ·Ï Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ È®ÀåÇÏ°í °­·ÂÇÑ °ø±Þ¸ÁÀ» ±¸ÃàÇϱâ À§ÇØ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¿ÍÀÇ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» Ȱ¿ëÇÏ´Â °ÍÀÌ Àü·«Àû ±ÇÀå »çÇ×ÀÔ´Ï´Ù. ȯÀÚ Àα¸ Åë°è¿Í Áö¿ª ¼ö¿ä¸¦ ÀÌÇØÇÏ´Â °ÍÀº ¸¶ÄÉÆÃ ¹× Á¦Ç° Àü·«À» È¿°úÀûÀ¸·Î ¸ÂÃãÈ­ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ¿¬µµ(2023³â) 2¾ï 1,711¸¸ ´Þ·¯
ÃßÁ¤¿¬µµ(2024³â) 2¾ï 3,613¸¸ ´Þ·¯
¿¹Ãø¿¬µµ(2030³â) 3¾ï 9,312¸¸ ´Þ·¯
CAGR(%) 8.85%

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ±¼Àý±³Á¤ ¼ö¼ú ±â±â ½ÃÀåÀÇ ÁÖ¿ä ÀλçÀÌÆ® °ø°³

±¼Àý±³Á¤ ¼ö¼ú ±â±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°èÀÇ ¶ó½Ä ¼ö¼ú °Ç¼ö Áõ°¡¿¡ ±âÀÎÇÏ´Â ÀáÀç ¼ö¿ä
    • ¾ÈÀå¾Ö¿¡ ´ëÇÑ ¿ì·Á Áõ°¡
    • ±¼Àý±³Á¤ ¼ö¼úÀÇ °íµµ·Î °ß°íÇÑ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±¼Àý±³Á¤ ¼ö¼ú ±â±âÀÇ µµÀÔ°ú ¼ö¼ú¿¡ µû¸¥ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • ÷´Ü Àåºñ ¾÷±×·¹À̵带 À§ÇÑ ÇコÄÉ¾î ºÐ¾ßÀÇ Áö¼ÓÀûÀÎ È®´ë
    • ÀÌÀ½»õ°¡ ÀûÀº ¼ö¼ú¹æ¹ý¿¡ ´ëÇÑ Á¤ºÎÀÇ À¯¸®ÇÑ ¹ý±ÔÁ¦
    • ¹«Åë ¼ö¼ú¿¡ ´ëÇÑ ÀûÀÀ Áõ°¡
  • ½ÃÀå °úÁ¦
    • ½ÅÈï±¹¿¡¼­ ±¼Àý±³Á¤ ¼ö¼ú °ü¸®ÀÇ ¼÷·Ã Àü¹®°¡ÀÇ ºÎÁ·

Porter's Five Forces : ±¼Àý±³Á¤ ¼ö¼ú Àåºñ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ºñÁî´Ï½º Á¶Á÷ÀÌ °æÀïÀû À§Ä¡¸¦ Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ý·ÐÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ÈûÀÇ ¿ªÇÐ °ü°è¸¦ Æò°¡ÇÏ°í »õ·Î¿î º¥Ã³ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϸç ÀáÀçÀûÀÎ ¹®Á¦¸¦ ¹æÁöÇÏ¿© º¸´Ù ź·ÂÀûÀÎ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ±¼Àý±³Á¤ ¼ö¼ú Àåºñ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ±¼Àý±³Á¤ ¼ö¼ú Àåºñ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡, °æÁ¦, »çȸ, ±â¼ú, ¹ý·ü ¹× ȯ°æ ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿Çâ º¯È­¸¦ ¿¹ÃøÇÏ¿© ¼±Á¦ÀûÀÌ°í ¹Ì·¡ ÁöÇâÀûÀÎ ÀÇ»ç °áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ±¼Àý±³Á¤ ¼ö¼ú ±â±â ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

±¼Àý±³Á¤ ¼ö¼ú Àåºñ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·ü µîÀÇ ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï ¿ìÀ§¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁßµµ, ¼¼ºÐÈ­, ÅëÇÕ Ãß¼¼¸¦ °­Á¶ÇÏ¿© º¥´õ°¡ °æÀïÀÌ Ä¡¿­ÇØÁö´Â ȯ°æ¿¡¼­ ÀÔÁö¸¦ °­È­ÇÏ´Â Àü·«Àû °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ±¼Àý±³Á¤ ¼ö¼ú Àåºñ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ±¼Àý±³Á¤ ¼ö¼ú Àåºñ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î º¥´õ¸¦ Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. 4°³ÀÇ »çºÐ¸éÀº °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© »ç¿ëÀÚ°¡ Àü·«Àû ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ±¼Àý±³Á¤ ¼ö¼ú Àåºñ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æ ã±â

±¼Àý±³Á¤ ¼ö¼ú ±â±â ½ÃÀåÀÇ Àü·«ºÐ¼®Àº ±Û·Î¹ú ½ÃÀå ÀÔÁö °­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø ¹× Àü·«Àû ±âȸ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ¿¬±¸ ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°è¿¡¼­ ¶ó½Ä ¼ö¼ú °Ç¼ö°¡ Áõ°¡Çϰí Àֱ⠶§¹®¿¡ ÀáÀçÀûÀÎ ¼ö¿ä°¡ Áõ°¡
      • ¾ÈÁúȯ¿¡ ´ëÇÑ ¿ì·Á Áõ°¡
      • ±¼Àý±³Á¤ ¼ö¼úÀÇ ¼±ÁøÀûÀÌ°í °­·ÂÇÑ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ±¼Àý±³Á¤ ¼ö¼ú ±â±â¸¦ ÀÌ¿ëÇÑ ¼³Ä¡³ª ¼ö¼ú¿¡ µû¸¥ °íºñ¿ë
    • ±âȸ
      • ÷´Ü Àåºñ ¾÷±×·¹À̵带 À§ÇÑ ÇコÄÉ¾î ºÐ¾ßÀÇ Áö¼ÓÀûÀÎ È®´ë
      • ºÀÇÕ ¾ø´Â ¼ö¼ú ¿É¼Ç¿¡ ´ëÇÑ Á¤ºÎÀÇ À¯¸®ÇÑ ¹ý·ü°ú ±ÔÁ¦
      • ÅëÁõÀÌ ¾ø´Â ¼ö¼ú¿¡ ÀûÀÀ Áõ°¡
    • °úÁ¦
      • ½ÅÈï±¹¿¡¼­ ±¼Àý±³Á¤ ¼ö¼ú °ü¸®ÀÇ ¼÷·Ã Àü¹®°¡ÀÇ ºÎÁ·
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
    • ¹ýÀû
    • ȯ°æÀû

Á¦6Àå ±¼Àý±³Á¤ ¼ö¼ú ±â±â ½ÃÀå : Á¦Ç° À¯Çüº°

  • ¼öÂ÷°è
  • ¸¶ÀÌÅ©·ÎÄɶóÅè
  • ¾È°ú¿ë ·¹ÀÌÀú
    • ¿¢½Ã¸Ó ·¹ÀÌÀú
    • ÆèÅäÃÊ ·¹ÀÌÀú
    • YAG ·¹ÀÌÀú

Á¦7Àå ±¼Àý±³Á¤ ¼ö¼ú ±â±â ½ÃÀå : ¿ëµµº°

  • ³­½Ã
  • ¾È±¸°ÇÁ¶Áõ
  • ¿ø½Ã(Farsightedness)
  • ¿ø½Ã(Hyperopia)
  • ±Ù½Ã(Myopia)
  • ±Ù½Ã(Nearsightedness)

Á¦8Àå ±¼Àý±³Á¤ ¼ö¼ú ±â±â ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • º´¿ø
  • ¾È°ú Ŭ¸®´Ð

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ±¼Àý±³Á¤ ¼ö¼ú ±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ ±¼Àý±³Á¤ ¼ö¼ú ±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ±¼Àý±³Á¤ ¼ö¼ú ±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Ãßõ

±â¾÷ ¸ñ·Ï

  • Alcon Vision LLC by Novartis AG
  • ARC Laser GmbH
  • Avedro, Inc. by Glaukos Corporation
  • Bausch Health Companies Inc.
  • Carl Zeiss Meditec AG
  • Ellex Medical by LUMIBIRD SA
  • ESSILOR INTERNATIONAL SAS
  • IRIDEX Corporation
  • iVIS Technologies Srl
  • Johnson&Johnson Services, Inc.
  • LIGHTMED CORPORATION
  • Lumenis Ltd.
  • NIDEK CO., LTD.
  • SCHWIND eye-tech-solutions GmbH
  • Ziemer Ophthalmic Systems AG
LYJ

The Refractive Surgery Devices Market was valued at USD 217.11 million in 2023, expected to reach USD 236.13 million in 2024, and is projected to grow at a CAGR of 8.85%, to USD 393.12 million by 2030.

Refractive surgery devices are specialized tools and technologies employed for correcting vision problems like myopia, hyperopia, and astigmatism, primarily through procedures such as LASIK, PRK, and SMILE. The necessity for these devices springs from the increasing prevalence of visual impairments and the rising preference for vision correction surgeries over traditional eyeglasses and contact lenses. They are applied mostly in eye care clinics and hospitals, catering to a diverse age group seeking permanent vision solutions. End-users include ophthalmologists and healthcare facilities that invest in these advanced devices to offer improved patient care. Key growth factors influencing the market include technological advancements in surgical devices, increasing patient awareness about refractive surgeries, and growing healthcare expenditure. Opportunities abound in emerging markets due to unpenetrated customer bases and potential partnerships with cutting-edge technology firms focusing on device innovation. However, market growth faces challenges such as high costs of devices, stringent regulatory frameworks, and potential risks associated with surgical procedures leading to patient hesitancy. Limitations also include lack of skilled professionals in developing regions and the availability of alternative non-surgical correction methods. To drive business growth, firms should focus on R&D to develop cost-effective, safe, and less invasive surgical methods. Innovation areas could include enhanced imaging systems for better precision and robotic surgery assistance. Due to rapid technological changes, competitive dynamics are intense, making the market highly innovation-driven. Companies investing in AI and machine learning to predict surgical outcomes can gain a competitive edge. Strategic recommendations include expanding product portfolios to include customizable solutions and leveraging strategic partnerships with healthcare providers to build robust supply chains. Understanding patient demographics and regional demands will be crucial to tailoring marketing and product strategies effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 217.11 million
Estimated Year [2024] USD 236.13 million
Forecast Year [2030] USD 393.12 million
CAGR (%) 8.85%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Refractive Surgery Devices Market

The Refractive Surgery Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Potential demand attributed to growing numbers of LASIK surgeries worldwide
    • Rising concerns regarding the eye disorders
    • Increasing investments in advanced and robust development of refractive surgeries
  • Market Restraints
    • High cost associated with installation and surgeries utilizing refractive surgery devices
  • Market Opportunities
    • Ongoing expansions of healthcare sectors to upgrade advanced devices
    • Favourable governmental laws and regulations for stitch less surgery options
    • Upsurging adaptations towards the painless surgeries
  • Market Challenges
    • Scarcity of skilled professionals in emerging economies for refracting surgery management

Porter's Five Forces: A Strategic Tool for Navigating the Refractive Surgery Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Refractive Surgery Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Refractive Surgery Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Refractive Surgery Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Refractive Surgery Devices Market

A detailed market share analysis in the Refractive Surgery Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Refractive Surgery Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Refractive Surgery Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Refractive Surgery Devices Market

A strategic analysis of the Refractive Surgery Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Refractive Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include Alcon Vision LLC by Novartis AG, ARC Laser GmbH, Avedro, Inc. by Glaukos Corporation, Bausch Health Companies Inc., Carl Zeiss Meditec AG, Ellex Medical by LUMIBIRD SA, ESSILOR INTERNATIONAL SAS, IRIDEX Corporation, iVIS Technologies S.r.l., Johnson & Johnson Services, Inc., LIGHTMED CORPORATION, Lumenis Ltd., NIDEK CO., LTD., SCHWIND eye-tech-solutions GmbH, and Ziemer Ophthalmic Systems AG.

Market Segmentation & Coverage

This research report categorizes the Refractive Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Aberrometers, Microkeratome, and Ophthalmic Laser. The Ophthalmic Laser is further studied across Excimer Laser, Femtosecond Laser, and YAG Laser.
  • Based on Application, market is studied across Astigmatism, Dry Eyes, Farsightedness, Hyperopia, Myopia, and Nearsightedness.
  • Based on End-Use, market is studied across Ambulatory Surgery Centers, Hospitals, and Ophthalmology Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Potential demand attributed to growing numbers of LASIK surgeries worldwide
      • 5.1.1.2. Rising concerns regarding the eye disorders
      • 5.1.1.3. Increasing investments in advanced and robust development of refractive surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with installation and surgeries utilizing refractive surgery devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing expansions of healthcare sectors to upgrade advanced devices
      • 5.1.3.2. Favourable governmental laws and regulations for stitch less surgery options
      • 5.1.3.3. Upsurging adaptations towards the painless surgeries
    • 5.1.4. Challenges
      • 5.1.4.1. Scarcity of skilled professionals in emerging economies for refracting surgery management
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Refractive Surgery Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Aberrometers
  • 6.3. Microkeratome
  • 6.4. Ophthalmic Laser
    • 6.4.1. Excimer Laser
    • 6.4.2. Femtosecond Laser
    • 6.4.3. YAG Laser

7. Refractive Surgery Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Astigmatism
  • 7.3. Dry Eyes
  • 7.4. Farsightedness
  • 7.5. Hyperopia
  • 7.6. Myopia
  • 7.7. Nearsightedness

8. Refractive Surgery Devices Market, by End-Use

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Hospitals
  • 8.4. Ophthalmology Clinics

9. Americas Refractive Surgery Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Refractive Surgery Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Refractive Surgery Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alcon Vision LLC by Novartis AG
  • 2. ARC Laser GmbH
  • 3. Avedro, Inc. by Glaukos Corporation
  • 4. Bausch Health Companies Inc.
  • 5. Carl Zeiss Meditec AG
  • 6. Ellex Medical by LUMIBIRD SA
  • 7. ESSILOR INTERNATIONAL SAS
  • 8. IRIDEX Corporation
  • 9. iVIS Technologies S.r.l.
  • 10. Johnson & Johnson Services, Inc.
  • 11. LIGHTMED CORPORATION
  • 12. Lumenis Ltd.
  • 13. NIDEK CO., LTD.
  • 14. SCHWIND eye-tech-solutions GmbH
  • 15. Ziemer Ophthalmic Systems AG
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦